{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:24:08Z","timestamp":1787847848339,"version":"build-2784847793"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pseudophakic cystoid macular edema (PCME) is one of the leading causes of reduced vision, after cataract surgery. Topical steroids and nonsteroidal anti-inflammatory drops are frequently used in the management; however, intravitreal injections may be required for chronic cases. Suprachoroidal injection of preservative free Triamcinolone acetonide is a recent addition to the therapeutic armamentarium of ophthalmologists for treatment of cystoid macular edema of varied etiology. Though the drug is commercially available at a reasonable cost, the microneedle is not commonly available. We modified a 26 G needle for safe and cost-effective delivery of preservative-free suprachoroidal triamcinolone acetonide (SCT). In the current series of three patients with non-resolving PCME, macular edema resolved and vision improved over 3 months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_1464_20","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T05:35:03Z","timestamp":1613540103000},"page":"765-767","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Modified inexpensive needle for suprachoroidal triamcinolone acetonide injections in pseudophakic cystoid macular edema"],"prefix":"10.4103","volume":"69","author":[{"given":"Avadhesh","family":"Oli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrikant","family":"Waikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-68-20240828","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcrs.2016.06.006","article-title":"Cataract surgery and nonsteroidal antiinflammatory drugs","volume":"42","author":"Hoffman","year":"2016","journal-title":"J Cataract Refract Surg"},{"key":"R2-68-20240828","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/OPTH.S98892","article-title":"Treatment costs of cystoid macular edema among patients following cataract surgery","volume":"10","author":"Schmier","year":"2016","journal-title":"Clin Ophthalmol (Auckland, NZ"},{"key":"R3-68-20240828","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/ceo.13513","article-title":"Cystoid macular oedema following cataract surgery: A review","volume":"47","author":"Han","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"R4-68-20240828","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.oret.2017.07.013","article-title":"Suprachoroidal triamcinolone acetonide for retinal vein occlusion: Results of the tanzanite study","volume":"2","author":"Campochiaro","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R5-68-20240828","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1167\/iovs.13-11747","article-title":"Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles","volume":"54","author":"Gilger","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-68-20240828","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1097\/IAE.0000000000002279","article-title":"Suprachoroidal injection of triamcinolone acetonide, CLS-TA, for macular edema due to noninfectious uveitis: A randomized, Phase 2 study (DOGWOOD)","volume":"39","author":"Yeh","year":"2019","journal-title":"Retina"},{"key":"R7-68-20240828","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.oret.2018.03.008","article-title":"Suprachoroidal triamcinolone acetonide for diabetic macular edema: The HULK Trial","volume":"2","author":"Wykoff","year":"2018","journal-title":"Ophthalmology Retina"},{"key":"R8-68-20240828","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2015.02.021","article-title":"Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model","volume":"203","author":"Chen","year":"2015","journal-title":"J Control Release"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1464_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:41:01Z","timestamp":1787845261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1464_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1464_20","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}